title: Malignant schwannoma following treatment for Hodgkin's disease.
abstract: Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease. Both patients survived for only 15 months. The aetiology of this rare condition is discussed.
authors.affiliation: Cookridge Hospital, Leeds, UK.
authors.forename: P M
authors.initials: PM
authors.lastname: Fisher
authors.forename: D J
authors.initials: DJ
authors.lastname: Dodwell
authors.forename: L R
authors.initials: LR
authors.lastname: Bridges
authors.forename: S C
authors.initials: SC
authors.lastname: Cartwright
authors.forename: J
authors.initials: J
authors.lastname: Stone
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D016609:Neoplasms, Second Primary / Q000473:pathology*; D009442:Neurilemmoma / Q000473:pathology*; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D013120:Spinal Cord Neoplasms / Q000473:pathology*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone